CEUFAST COURSE

HIPAA for the CNA

Contact Hour(s): 1.5 Contact HoursAuthor:Celeste Barefield, MSN, APRN, FNP-BCThis peer-reviewed course is applicable for the following professions:Certified Medication Assistant (CMA), Certified Nursing Assistant (CNA), Home Health Aid (...

Course Summary

Contact Hour(s): 

1.5 Contact Hours

Author:

Celeste Barefield, MSN, APRN, FNP-BC

This peer-reviewed course is applicable for the following professions:

Certified Medication Assistant (CMA), Certified Nursing Assistant (CNA), Home Health Aid (HHA), Licensed Nursing Assistant (LNA), Medical Assistant (MA)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Florida Board of Nursing Provider 50-353


Course Description:

This course discusses and defines HIPAA, PHI, and Patient Rights. Also, how the CNA may encounter HIPAA, PHI, and the Minimum Necessary Rule in the workplace, with real-world scenarios and examples of how to deal with violations one-on-one and with the covered entity. Special cases where PHI may be given without consent. A straightforward three-question decision tree for determining if information is PHI is provided.

Outcomes:

≥ 92% of participants will know the rules related to HIPAA, what constitutes HIPAA violations, and how to remain compliant.

Objectives:

After completing this continuing education course, the participant will be able to:

  1. Determine two common HIPAA violations they might encounter in their daily work.
  2. Identify the proper course of action to avoid common HIPAA errors.
  3. Define Protected Health Information and recognize examples of Protected Health Information (PHI).
  4. Outline who to contact to report HIPAA violations.
  5. Define the Minimum Necessary Rule.
  6. Explain consent and identify special cases where consent is not needed to share PHI.
  7. Outline legal and civil consequences of violating Federal HIPAA laws.


Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.